A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
INCB 57643-103
Phase 1 other active
Quick answer
A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms for Treatment of participants with MF, MDS, ET, or MDS/MPN is a Phase 1 program (other) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte Biosciences Distribution B.V.
- Indication
- Treatment of participants with MF, MDS, ET, or MDS/MPN
- Phase
- Phase 1
- Modality
- other
- Status
- active